Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis

被引:21
作者
Yuan, Jun [1 ]
Xu, Guang Ma [1 ]
机构
[1] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Cardiol, Nanning 530021, Guangxi, Peoples R China
关键词
NONDIABETIC PATIENTS; OUTCOMES; EVEROLIMUS;
D O I
10.1007/s40256-018-0295-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Nowadays, drug-eluting stents (DES) are most commonly used compared with bare metal stents (BMS) since the former are associated with significantly lower rates of revascularization following percutaneous coronary intervention (PCI). However, unpredictable in-stent thrombosis is a major concern with DES, especially in patients with diabetes mellitus. Objective In this analysis, we aimed to systematically compare early and late stent thrombosis in patients with versus without diabetes mellitus following PCI with DES. Methods Studies were included if they were randomized controlled trials or observational studies comparing patients with diabetes mellitus versus those without it following PCI with DES and they reported acute and sub-acute/early and late stent thrombosis among their clinical outcomes. Early stent thrombosis was defined as stent thrombosis that occurred before 30days and late stent thrombosis was defined as stent thrombosis that occurred after 30days following PCI. The statistical analysis was carried out by the new version of the RevMan software (version 5.3), and odds ratios (ORs) and 95% confidence intervals (CIs) were considered as the statistical parameters. Results A total number of 18,910 patients were included in this analysis comparing early and late stent thrombosis in patients with diabetes mellitus (5123 patients) and in patients without diabetes mellitus (13,787 patients). Both groups of patients had similar rates of early stent thrombosis, with an OR of 1.30 (95% CI 0.89-1.91; P=0.18, I-2=9%) (4962 patients with diabetes mellitus were compared with 13,392 patients without diabetes mellitus). However, late stent thrombosis was significantly higher in patients with diabetes mellitus, with an OR of 1.95 (95% CI 1.35- 2.81; P=0.0004, I-2=0%) (5113 patients with diabetes mellitus and 13,775 patients without diabetes mellitus were compared). Conclusions Both patients with and without diabetes mellitus had a similar rate of early stent thrombosis following PCI with DES. However, diabetes mellitus was associated with a significantly higher rate of late stent thrombosis.
引用
收藏
页码:483 / 492
页数:10
相关论文
共 23 条
[1]   Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling - Are Useful Drugs Already Available? [J].
Arthur, Jane F. ;
Jandeleit-Dahm, Karin ;
Andrews, Robert K. .
DIABETES, 2017, 66 (01) :7-13
[2]   Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2) [J].
Asher, Elad ;
Abu-Much, Arsalan ;
Goldenberg, Ilan ;
Segev, Amit ;
Sabbag, Avi ;
Mazin, Israel ;
Shlezinger, Meital ;
Atar, Shaul ;
Zahger, Doron ;
Polak, Arthur ;
Beigel, Roy ;
Matetzky, Shlomi .
PLOS ONE, 2016, 11 (06)
[3]   Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents [J].
Banning, Adrian P. ;
Westaby, Stephen ;
Morice, Marie-Claude ;
Kappetein, A. Pieter ;
Mohr, Friedrich W. ;
Berti, Sergio ;
Glauber, Mattia ;
Kellett, Mirle A. ;
Kramer, Robert S. ;
Leadley, Katrin ;
Dawkins, Keith D. ;
Serruys, Patrick W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) :1067-1075
[4]   Very Late Stent Thrombosis After Primary Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction A 15-Year Single-Center Experience [J].
Brodie, Bruce ;
Pokharel, Yashashwi ;
Fleishman, Nathan ;
Bensimhon, Adam ;
Kissling, Grace ;
Hansen, Charles ;
Milks, Sally ;
Cooper, Michael ;
McAlhany, Christopher ;
Stuckey, Tom .
JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (01) :30-38
[5]   Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease A systematic review and meta-analysis [J].
Bundhun, Pravesh Kumar ;
Soogund, M. Zafooruddin Sani ;
Pursun, Manish ;
Chen, Meng-Hua .
MEDICINE, 2016, 95 (27)
[6]   Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials [J].
Bundhun, Pravesh Kumar ;
Bhurtu, Akash ;
Soogund, Mohammad Zafooruddin Sani ;
Long, Man-Yun .
PLOS ONE, 2016, 11 (04)
[7]   Early (≤ 30 Days), Late (31-360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis [J].
Chen, Wei ;
Wu, Yubin ;
Hu, Yubao .
DIABETES THERAPY, 2018, 9 (03) :1113-1124
[8]   Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents Prespecified Subgroup Analysis of the BIOSCIENCE Trial [J].
Franzone, Anna ;
Pilgrim, Thomas ;
Heg, Dik ;
Roffi, Marco ;
Tueller, David ;
Vuilliomenet, Andre ;
Muller, Olivier ;
Cook, Stephane ;
Weilenmann, Daniel ;
Kaiser, Christoph ;
Jamshidi, Peiman ;
Raeber, Lorenz ;
Stortecky, Stefan ;
Wenaweser, Peter ;
Jueni, Peter ;
Windecker, Stephan .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (06)
[9]   Measuring inconsistency in meta-analyses [J].
Higgins, JPT ;
Thompson, SG ;
Deeks, JJ ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :557-560
[10]   Platelets and diabetes: A complex association [J].
Jagroop, Anita ;
Mikhailidis, Dimitri P. .
PLATELETS, 2015, 26 (03) :267-268